CORRECTION:Jefferies analyst Kelly Shi initiates coverage on CTI BioPharma (NASDAQ:CTIC) with a Buy rating and announces Price Target of $13, correct Analyst Firm updated.
Playboy And Cannabis Accessories Brand Team Up To ‘Destigmatize The Use Of Cannabis By Women’
Sackville & Co., a design-centric cannabis accessories brand, announced its collaboration with Playboy, the globally-recognized, lifestyle brand owned by PLBY Group Inc. (NASDAQ: PLBY) Launching April 20th, the two-piece collaboration will include
